Transformative Melanoma Drugs; Price Risks: BI Deep Dive
Автор: Bloomberg Intelligence
Загружено: 2024-04-25
Просмотров: 178
Описание:
The market for melanoma drugs could reach almost $11 billion in 2027, based on a Bloomberg Intelligence market-size scenario, from $8 billion in 2023, though growth could halt in 2028 due to mandatory US government price cuts for standards of care including Bristol Myers’ Opdivo and Merck & Co.’s Keytruda. Bristol Myers’ next-generation Opdualag and new drugs from Regeneron, Iovance and Immunocore provide upside, but need strong launches. Max Nisen, BI biotech & pharmaceuticals analyst, highlights the latest insights from of the Melanoma Deep Dive report published.
Link to the report: https://blinks.bloomberg.com/news/sto...
This video was produced and edited by Mariam Traore.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
